Recruiting

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.

ClinicalTrials.gov IDNCT07183657

PhaseNA

Enrollment1000

SponsorCharles University, Czech Republic

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Chronic Obstructive Pulmonary Disease (COPD), Bronchial Asthma

About this study

Interventions

Other: Education in inhalation technique — Education in inhalation technique

Primary outcomes

Adherence to inhaled treatment measured by Five Steps Assessment (FSA). (Assessment of adherence to inhaled treatment within 12 months.)
Adherence to inhaled treatment measured by the Medication Adherence Report Scale (MARS). (Assessment of adherence to inhaled treatment within 12 months.)
Critical knowledge measured by our own questionnaire in healthcare professionals caring for patients with COPD and bronchial asthma. (Critical knowledge related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma within 12 months)
Critical skills related to inhalation techniques measured by FSA in healthcare professionals caring for patients with COPD and bronchial asthma. (Critical skills related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma within 12 months.)

Eligibility information

PATIENTS Inclusion Criteria: 1. signed informed consent, 2. age ≥ 18 years, 3. previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria, 4. ability to cooperate, 5. at least 8 weeks without exacerbation, 6. use of a particular inhaler for at least 3 months. Exclusion Criteria: 1. pre-terminal/terminal stage of any disease, 2. uncooperative patient, 3. significant limitation of mobility or cognitive functions. HEALTHCARE PROFESSIONALS Inclusion Criteria: 1. signed informed consent, 2. completed education in medicine, pharmacy, or nursing, 3. more than one year of working experience, 4. care for patients taking inhaled therapy for BA/COPD.

Study locations

University Hospital Hradec Králové, Hradec Králové, 500 05 Czechia

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.